All About SOT Therapy

SOT is Supportive Oligodeoxynucleotide Technique.  This is a treatment for specific infections including certain viruses like Epstein Barr, HPV, and HIV and bacterial infections such as Lyme disease and Bartonella.  Cancer also responds well to SOT.

This therapy utilizes messenger RNA that is found naturally in the patient’s own body; therefore it is not a drug therapy.  SOT is not a new therapy; it began about 10 years ago at RGCC labs in Greece.  It has been backed by many years of research by both European and American companies and universities.  Now, thousands of patients worldwide have had benefits from this unique and effective therapy.

“Oligo” means “few,” and nucleotides are the molecules that form the structure of DNA and RNA.  Thus, SOT consists of a short sequence of nucleotides rarely no longer than 20 amino acids long.  These oligonucleotides bind to the pathogens in the body and effectively block their function and ability to reproduce.  Each treatment is uniquely tailored to a person’s individual needs.

Much scientific research on SOT therapy has been done within the last few years and continues today.  SOT can now effectively halt the replication cycles for 24 species of Lyme disease and some Lyme disease co-infections as well.  The SOT molecules very slowly degrade in the body and can therefore attack the Lyme or viral cells for up to 6 months.

Blood is drawn from the patient and sent to the RGCC lab in Greece where they identify specific gene sequences of the infectious agent.  The lab then verifies this by cross-referencing the main gene sequences with information stored in an international database, thus “fingerprinting” the pathogen for a 98% accuracy rate.  This makes it possible to maximize the success of treatment.  Once identified, the lab creates an anti-copy of specific replication sequences that inhibit the pathogen from further reproducing.  SOT does not interfere with the functioning of normal cells, tissues, or organs.  SOT only influences specific gene expressions and does NOT change gene structure.  This is NOT genetic therapy.  SOT is also not an immune therapy and does not work through the immune activation system.

Once the gene sequence is identified and personalized for each individual, the RGCC lab ships the SOT to our office where we will administer it to the patient via a short IV infusion.  The SOT penetrates the cell wall of the infecting organism.  After that, the SOT will work around the clock for about six months, during which time they will continue to inhibit the replication of the specific target infections. The next lifecycle of the pathogen is thereby halted.  Follow-up testing is strongly recommended to help verify the treatment is being effective.

In order to identify the specific target in each patient, a positive test result within 6 months must be supplied to the lab.  If you do not have current testing, Healing Arts can order testing for you as needed.

Please note that if a patient has multiple active infections, individual SOT treatments will be needed for each infection.  At times, more than one SOT treatment may be needed for a single infection.  In addition, note that a person can still become infected with a new organism during SOT treatment for an existing infection. A person can become re-infected with the SAME organism once the immune system has decreased its response, anywhere from 1 to 6 years. Avoidance/prevention measures should be adhered to.

Side effects of SOT may include headaches, body aches, general malaise, sweating, diarrhea, cough, mild fever, and mild to moderate flu-like symptoms.  Usually, these symptoms resolve in 24-48 hours.  The symptoms are similar to a “Herx” reaction and may occur from time to time during the 6-month time period depending on the lifecycle of the infecting organism.

The GOAL of SOT therapy for viral infections is to have the viral load down to normal, which usually takes 1 to 3 treatments within a 12-month period. The goal for bacterial infections is to have less than 5 cells per unit. Patients can have 3 SOT treatments per year for any single target and up to 3 targets per year (9 total treatments). Follow-up testing may be required after 4-5 months, as well as general lab work. A new blood draw is required for every SOT.

Visit here for an informative video on SOT:

Share this article: